A detailed history of State Of Alaska, Department Of Revenue transactions in Abb Vie Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 299,734 shares of ABBV stock, worth $49.8 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
299,734
Previous 311,644 3.82%
Holding current value
$49.8 Million
Previous $53.5 Million 10.73%
% of portfolio
0.63%
Previous 0.6%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $1.95 Million - $2.37 Million
-11,910 Reduced 3.82%
299,734 $59.2 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $2.46 Million - $2.87 Million
15,885 Added 5.37%
311,644 $53.5 Million
Q1 2024

Apr 19, 2024

SELL
$159.82 - $182.1 $1.64 Million - $1.86 Million
-10,235 Reduced 3.34%
295,759 $53.9 Million
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $1.87 Million - $2.1 Million
-13,555 Reduced 4.24%
305,994 $47.4 Million
Q3 2023

Oct 16, 2023

SELL
$133.59 - $154.65 $1.15 Million - $1.33 Million
-8,590 Reduced 2.62%
319,549 $47.6 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $1.51 Million - $1.87 Million
11,369 Added 3.59%
328,139 $44.2 Million
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $533,755 - $614,699
-3,691 Reduced 1.15%
316,770 $50.5 Million
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $195,985 - $235,037
1,417 Added 0.44%
320,461 $51.8 Million
Q3 2022

Oct 20, 2022

SELL
$134.21 - $153.93 $1.13 Million - $1.3 Million
-8,438 Reduced 2.58%
319,044 $42.8 Million
Q2 2022

Jul 08, 2022

BUY
$137.62 - $174.96 $2.84 Million - $3.6 Million
20,601 Added 6.71%
327,482 $50.2 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $1.02 Million - $1.27 Million
-7,731 Reduced 2.46%
306,881 $49.7 Million
Q4 2021

Jan 12, 2022

SELL
$107.43 - $135.93 $1.72 Million - $2.18 Million
-16,018 Reduced 4.84%
314,612 $42.6 Million
Q3 2021

Oct 07, 2021

BUY
$106.4 - $120.78 $2.75 Million - $3.12 Million
25,864 Added 8.49%
330,630 $35.7 Million
Q2 2021

Jul 12, 2021

BUY
$105.21 - $117.21 $459,978 - $512,442
4,372 Added 1.46%
304,766 $34.3 Million
Q1 2021

Apr 09, 2021

BUY
$102.3 - $112.62 $240,814 - $265,107
2,354 Added 0.79%
300,394 $32.5 Million
Q4 2020

Jan 08, 2021

SELL
$80.49 - $108.67 $816,973 - $1.1 Million
-10,150 Reduced 3.29%
298,040 $31.9 Million
Q3 2020

Oct 05, 2020

SELL
$85.91 - $100.83 $3.39 Million - $3.98 Million
-39,517 Reduced 11.37%
308,190 $27 Million
Q2 2020

Jul 06, 2020

BUY
$73.37 - $98.18 $6.66 Million - $8.91 Million
90,797 Added 35.34%
347,707 $34.1 Million
Q1 2020

Apr 06, 2020

BUY
$64.5 - $97.79 $894,873 - $1.36 Million
13,874 Added 5.71%
256,910 $19.6 Million
Q4 2019

Jan 07, 2020

SELL
$72.13 - $90.25 $1.44 Million - $1.8 Million
-19,968 Reduced 7.59%
243,036 $21.5 Million
Q3 2019

Oct 02, 2019

BUY
$62.98 - $75.72 $3.82 Million - $4.59 Million
60,664 Added 29.98%
263,004 $19.9 Million
Q2 2019

Jul 23, 2019

BUY
$65.7 - $83.98 $64,057 - $81,880
975 Added 0.48%
202,340 $14.7 Million
Q1 2019

Apr 09, 2019

SELL
$77.14 - $90.79 $2.04 Million - $2.4 Million
-26,439 Reduced 11.61%
201,365 $16.2 Million
Q4 2018

Jan 10, 2019

BUY
$77.85 - $96.01 $151,184 - $186,451
1,942 Added 0.86%
227,804 $21 Million
Q3 2018

Oct 09, 2018

SELL
$88.91 - $98.84 $670,114 - $744,957
-7,537 Reduced 3.23%
225,862 $21.4 Million
Q2 2018

Jul 10, 2018

BUY
$89.78 - $106.23 $3.98 Million - $4.7 Million
44,276 Added 23.41%
233,399 $21.6 Million
Q1 2018

Apr 19, 2018

BUY
$92.01 - $123.21 $1.25 Million - $1.67 Million
13,560 Added 7.72%
189,123 $17.9 Million
Q4 2017

Jan 19, 2018

BUY
$89.56 - $98.21 $13.4 Million - $14.7 Million
149,538 Added 574.59%
175,563 $17 Million
Q3 2017

Oct 16, 2017

BUY
$69.85 - $89.22 $1.82 Million - $2.32 Million
26,025
26,025 $2.31 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.